The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Imipenem API Market Research Report 2024
Synopsis
The global Imipenem API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Imipenem API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imipenem API.
Report Scope
The Imipenem API market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imipenem API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imipenem API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira
ACS DOBFAR SPA
High Science
Jeil Pharmaceutica
Choongwae Pharma Corporation
Sun Pharmaceutical
Sandoz
Kaliberr
Auronext Pharma
Nectar Lifesciences
Savior Lifetec Corporation
Zhuhai United Laboratorie
SUZHOU HOMESUN PHARMACEUTICAL
Unimark Remedies
Zhejiang Haixiang Pharmaceutical
Segment by Type
Aseptic API
Non-sterile API
Segment by Application
Intramuscular Injection
Static Drops
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imipenem API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imipenem API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Imipenem API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Imipenem API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imipenem API.
Report Scope
The Imipenem API market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imipenem API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imipenem API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hospira
ACS DOBFAR SPA
High Science
Jeil Pharmaceutica
Choongwae Pharma Corporation
Sun Pharmaceutical
Sandoz
Kaliberr
Auronext Pharma
Nectar Lifesciences
Savior Lifetec Corporation
Zhuhai United Laboratorie
SUZHOU HOMESUN PHARMACEUTICAL
Unimark Remedies
Zhejiang Haixiang Pharmaceutical
Segment by Type
Aseptic API
Non-sterile API
Segment by Application
Intramuscular Injection
Static Drops
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Imipenem API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Imipenem API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Imipenem API Market Overview
1.1 Product Overview and Scope of Imipenem API
1.2 Imipenem API Segment by Type
1.2.1 Global Imipenem API Market Value Comparison by Type (2024-2030)
1.2.2 Aseptic API
1.2.3 Non-sterile API
1.3 Imipenem API Segment by Application
1.3.1 Global Imipenem API Market Value by Application: (2024-2030)
1.3.2 Intramuscular Injection
1.3.3 Static Drops
1.4 Global Imipenem API Market Size Estimates and Forecasts
1.4.1 Global Imipenem API Revenue 2019-2030
1.4.2 Global Imipenem API Sales 2019-2030
1.4.3 Global Imipenem API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Imipenem API Market Competition by Manufacturers
2.1 Global Imipenem API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Imipenem API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Imipenem API Average Price by Manufacturers (2019-2024)
2.4 Global Imipenem API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Imipenem API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Imipenem API, Product Type & Application
2.7 Imipenem API Market Competitive Situation and Trends
2.7.1 Imipenem API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Imipenem API Players Market Share by Revenue
2.7.3 Global Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Imipenem API Retrospective Market Scenario by Region
3.1 Global Imipenem API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Imipenem API Global Imipenem API Sales by Region: 2019-2030
3.2.1 Global Imipenem API Sales by Region: 2019-2024
3.2.2 Global Imipenem API Sales by Region: 2025-2030
3.3 Global Imipenem API Global Imipenem API Revenue by Region: 2019-2030
3.3.1 Global Imipenem API Revenue by Region: 2019-2024
3.3.2 Global Imipenem API Revenue by Region: 2025-2030
3.4 North America Imipenem API Market Facts & Figures by Country
3.4.1 North America Imipenem API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Imipenem API Sales by Country (2019-2030)
3.4.3 North America Imipenem API Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Imipenem API Market Facts & Figures by Country
3.5.1 Europe Imipenem API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Imipenem API Sales by Country (2019-2030)
3.5.3 Europe Imipenem API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Imipenem API Market Facts & Figures by Country
3.6.1 Asia Pacific Imipenem API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Imipenem API Sales by Country (2019-2030)
3.6.3 Asia Pacific Imipenem API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Imipenem API Market Facts & Figures by Country
3.7.1 Latin America Imipenem API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Imipenem API Sales by Country (2019-2030)
3.7.3 Latin America Imipenem API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Imipenem API Market Facts & Figures by Country
3.8.1 Middle East and Africa Imipenem API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Imipenem API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Imipenem API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Imipenem API Sales by Type (2019-2030)
4.1.1 Global Imipenem API Sales by Type (2019-2024)
4.1.2 Global Imipenem API Sales by Type (2025-2030)
4.1.3 Global Imipenem API Sales Market Share by Type (2019-2030)
4.2 Global Imipenem API Revenue by Type (2019-2030)
4.2.1 Global Imipenem API Revenue by Type (2019-2024)
4.2.2 Global Imipenem API Revenue by Type (2025-2030)
4.2.3 Global Imipenem API Revenue Market Share by Type (2019-2030)
4.3 Global Imipenem API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Imipenem API Sales by Application (2019-2030)
5.1.1 Global Imipenem API Sales by Application (2019-2024)
5.1.2 Global Imipenem API Sales by Application (2025-2030)
5.1.3 Global Imipenem API Sales Market Share by Application (2019-2030)
5.2 Global Imipenem API Revenue by Application (2019-2030)
5.2.1 Global Imipenem API Revenue by Application (2019-2024)
5.2.2 Global Imipenem API Revenue by Application (2025-2030)
5.2.3 Global Imipenem API Revenue Market Share by Application (2019-2030)
5.3 Global Imipenem API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hospira
6.1.1 Hospira Corporation Information
6.1.2 Hospira Description and Business Overview
6.1.3 Hospira Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hospira Imipenem API Product Portfolio
6.1.5 Hospira Recent Developments/Updates
6.2 ACS DOBFAR SPA
6.2.1 ACS DOBFAR SPA Corporation Information
6.2.2 ACS DOBFAR SPA Description and Business Overview
6.2.3 ACS DOBFAR SPA Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ACS DOBFAR SPA Imipenem API Product Portfolio
6.2.5 ACS DOBFAR SPA Recent Developments/Updates
6.3 High Science
6.3.1 High Science Corporation Information
6.3.2 High Science Description and Business Overview
6.3.3 High Science Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 High Science Imipenem API Product Portfolio
6.3.5 High Science Recent Developments/Updates
6.4 Jeil Pharmaceutica
6.4.1 Jeil Pharmaceutica Corporation Information
6.4.2 Jeil Pharmaceutica Description and Business Overview
6.4.3 Jeil Pharmaceutica Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Jeil Pharmaceutica Imipenem API Product Portfolio
6.4.5 Jeil Pharmaceutica Recent Developments/Updates
6.5 Choongwae Pharma Corporation
6.5.1 Choongwae Pharma Corporation Corporation Information
6.5.2 Choongwae Pharma Corporation Description and Business Overview
6.5.3 Choongwae Pharma Corporation Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Choongwae Pharma Corporation Imipenem API Product Portfolio
6.5.5 Choongwae Pharma Corporation Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Imipenem API Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Imipenem API Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
6.8 Kaliberr
6.8.1 Kaliberr Corporation Information
6.8.2 Kaliberr Description and Business Overview
6.8.3 Kaliberr Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Kaliberr Imipenem API Product Portfolio
6.8.5 Kaliberr Recent Developments/Updates
6.9 Auronext Pharma
6.9.1 Auronext Pharma Corporation Information
6.9.2 Auronext Pharma Description and Business Overview
6.9.3 Auronext Pharma Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Auronext Pharma Imipenem API Product Portfolio
6.9.5 Auronext Pharma Recent Developments/Updates
6.10 Nectar Lifesciences
6.10.1 Nectar Lifesciences Corporation Information
6.10.2 Nectar Lifesciences Description and Business Overview
6.10.3 Nectar Lifesciences Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nectar Lifesciences Imipenem API Product Portfolio
6.10.5 Nectar Lifesciences Recent Developments/Updates
6.11 Savior Lifetec Corporation
6.11.1 Savior Lifetec Corporation Corporation Information
6.11.2 Savior Lifetec Corporation Imipenem API Description and Business Overview
6.11.3 Savior Lifetec Corporation Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Savior Lifetec Corporation Imipenem API Product Portfolio
6.11.5 Savior Lifetec Corporation Recent Developments/Updates
6.12 Zhuhai United Laboratorie
6.12.1 Zhuhai United Laboratorie Corporation Information
6.12.2 Zhuhai United Laboratorie Imipenem API Description and Business Overview
6.12.3 Zhuhai United Laboratorie Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Zhuhai United Laboratorie Imipenem API Product Portfolio
6.12.5 Zhuhai United Laboratorie Recent Developments/Updates
6.13 SUZHOU HOMESUN PHARMACEUTICAL
6.13.1 SUZHOU HOMESUN PHARMACEUTICAL Corporation Information
6.13.2 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Description and Business Overview
6.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product Portfolio
6.13.5 SUZHOU HOMESUN PHARMACEUTICAL Recent Developments/Updates
6.14 Unimark Remedies
6.14.1 Unimark Remedies Corporation Information
6.14.2 Unimark Remedies Imipenem API Description and Business Overview
6.14.3 Unimark Remedies Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Unimark Remedies Imipenem API Product Portfolio
6.14.5 Unimark Remedies Recent Developments/Updates
6.15 Zhejiang Haixiang Pharmaceutical
6.15.1 Zhejiang Haixiang Pharmaceutical Corporation Information
6.15.2 Zhejiang Haixiang Pharmaceutical Imipenem API Description and Business Overview
6.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zhejiang Haixiang Pharmaceutical Imipenem API Product Portfolio
6.15.5 Zhejiang Haixiang Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Imipenem API Industry Chain Analysis
7.2 Imipenem API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Imipenem API Production Mode & Process
7.4 Imipenem API Sales and Marketing
7.4.1 Imipenem API Sales Channels
7.4.2 Imipenem API Distributors
7.5 Imipenem API Customers
8 Imipenem API Market Dynamics
8.1 Imipenem API Industry Trends
8.2 Imipenem API Market Drivers
8.3 Imipenem API Market Challenges
8.4 Imipenem API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Imipenem API Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Imipenem API Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Imipenem API Market Competitive Situation by Manufacturers in 2023
Table 4. Global Imipenem API Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Imipenem API Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Imipenem API Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Imipenem API Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Imipenem API Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Imipenem API, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Imipenem API, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Imipenem API, Product Type & Application
Table 12. Global Key Manufacturers of Imipenem API, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Imipenem API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imipenem API as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Imipenem API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Imipenem API Sales by Region (2019-2024) & (KG)
Table 18. Global Imipenem API Sales Market Share by Region (2019-2024)
Table 19. Global Imipenem API Sales by Region (2025-2030) & (KG)
Table 20. Global Imipenem API Sales Market Share by Region (2025-2030)
Table 21. Global Imipenem API Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Imipenem API Revenue Market Share by Region (2019-2024)
Table 23. Global Imipenem API Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Imipenem API Revenue Market Share by Region (2025-2030)
Table 25. North America Imipenem API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Imipenem API Sales by Country (2019-2024) & (KG)
Table 27. North America Imipenem API Sales by Country (2025-2030) & (KG)
Table 28. North America Imipenem API Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Imipenem API Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Imipenem API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Imipenem API Sales by Country (2019-2024) & (KG)
Table 32. Europe Imipenem API Sales by Country (2025-2030) & (KG)
Table 33. Europe Imipenem API Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Imipenem API Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Imipenem API Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Imipenem API Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Imipenem API Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Imipenem API Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Imipenem API Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Imipenem API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Imipenem API Sales by Country (2019-2024) & (KG)
Table 42. Latin America Imipenem API Sales by Country (2025-2030) & (KG)
Table 43. Latin America Imipenem API Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Imipenem API Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Imipenem API Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Imipenem API Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Imipenem API Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Imipenem API Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Imipenem API Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Imipenem API Sales (KG) by Type (2019-2024)
Table 51. Global Imipenem API Sales (KG) by Type (2025-2030)
Table 52. Global Imipenem API Sales Market Share by Type (2019-2024)
Table 53. Global Imipenem API Sales Market Share by Type (2025-2030)
Table 54. Global Imipenem API Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Imipenem API Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Imipenem API Revenue Market Share by Type (2019-2024)
Table 57. Global Imipenem API Revenue Market Share by Type (2025-2030)
Table 58. Global Imipenem API Price (US$/G) by Type (2019-2024)
Table 59. Global Imipenem API Price (US$/G) by Type (2025-2030)
Table 60. Global Imipenem API Sales (KG) by Application (2019-2024)
Table 61. Global Imipenem API Sales (KG) by Application (2025-2030)
Table 62. Global Imipenem API Sales Market Share by Application (2019-2024)
Table 63. Global Imipenem API Sales Market Share by Application (2025-2030)
Table 64. Global Imipenem API Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Imipenem API Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Imipenem API Revenue Market Share by Application (2019-2024)
Table 67. Global Imipenem API Revenue Market Share by Application (2025-2030)
Table 68. Global Imipenem API Price (US$/G) by Application (2019-2024)
Table 69. Global Imipenem API Price (US$/G) by Application (2025-2030)
Table 70. Hospira Corporation Information
Table 71. Hospira Description and Business Overview
Table 72. Hospira Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Hospira Imipenem API Product
Table 74. Hospira Recent Developments/Updates
Table 75. ACS DOBFAR SPA Corporation Information
Table 76. ACS DOBFAR SPA Description and Business Overview
Table 77. ACS DOBFAR SPA Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. ACS DOBFAR SPA Imipenem API Product
Table 79. ACS DOBFAR SPA Recent Developments/Updates
Table 80. High Science Corporation Information
Table 81. High Science Description and Business Overview
Table 82. High Science Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. High Science Imipenem API Product
Table 84. High Science Recent Developments/Updates
Table 85. Jeil Pharmaceutica Corporation Information
Table 86. Jeil Pharmaceutica Description and Business Overview
Table 87. Jeil Pharmaceutica Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Jeil Pharmaceutica Imipenem API Product
Table 89. Jeil Pharmaceutica Recent Developments/Updates
Table 90. Choongwae Pharma Corporation Corporation Information
Table 91. Choongwae Pharma Corporation Description and Business Overview
Table 92. Choongwae Pharma Corporation Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Choongwae Pharma Corporation Imipenem API Product
Table 94. Choongwae Pharma Corporation Recent Developments/Updates
Table 95. Sun Pharmaceutical Corporation Information
Table 96. Sun Pharmaceutical Description and Business Overview
Table 97. Sun Pharmaceutical Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 98. Sun Pharmaceutical Imipenem API Product
Table 99. Sun Pharmaceutical Recent Developments/Updates
Table 100. Sandoz Corporation Information
Table 101. Sandoz Description and Business Overview
Table 102. Sandoz Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 103. Sandoz Imipenem API Product
Table 104. Sandoz Recent Developments/Updates
Table 105. Kaliberr Corporation Information
Table 106. Kaliberr Description and Business Overview
Table 107. Kaliberr Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 108. Kaliberr Imipenem API Product
Table 109. Kaliberr Recent Developments/Updates
Table 110. Auronext Pharma Corporation Information
Table 111. Auronext Pharma Description and Business Overview
Table 112. Auronext Pharma Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 113. Auronext Pharma Imipenem API Product
Table 114. Auronext Pharma Recent Developments/Updates
Table 115. Nectar Lifesciences Corporation Information
Table 116. Nectar Lifesciences Description and Business Overview
Table 117. Nectar Lifesciences Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 118. Nectar Lifesciences Imipenem API Product
Table 119. Nectar Lifesciences Recent Developments/Updates
Table 120. Savior Lifetec Corporation Corporation Information
Table 121. Savior Lifetec Corporation Description and Business Overview
Table 122. Savior Lifetec Corporation Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 123. Savior Lifetec Corporation Imipenem API Product
Table 124. Savior Lifetec Corporation Recent Developments/Updates
Table 125. Zhuhai United Laboratorie Corporation Information
Table 126. Zhuhai United Laboratorie Description and Business Overview
Table 127. Zhuhai United Laboratorie Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 128. Zhuhai United Laboratorie Imipenem API Product
Table 129. Zhuhai United Laboratorie Recent Developments/Updates
Table 130. SUZHOU HOMESUN PHARMACEUTICAL Corporation Information
Table 131. SUZHOU HOMESUN PHARMACEUTICAL Description and Business Overview
Table 132. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 133. SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product
Table 134. SUZHOU HOMESUN PHARMACEUTICAL Recent Developments/Updates
Table 135. Unimark Remedies Corporation Information
Table 136. Unimark Remedies Description and Business Overview
Table 137. Unimark Remedies Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 138. Unimark Remedies Imipenem API Product
Table 139. Unimark Remedies Recent Developments/Updates
Table 140. Zhejiang Haixiang Pharmaceutical Corporation Information
Table 141. Zhejiang Haixiang Pharmaceutical Description and Business Overview
Table 142. Zhejiang Haixiang Pharmaceutical Imipenem API Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 143. Zhejiang Haixiang Pharmaceutical Imipenem API Product
Table 144. Zhejiang Haixiang Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Imipenem API Distributors List
Table 148. Imipenem API Customers List
Table 149. Imipenem API Market Trends
Table 150. Imipenem API Market Drivers
Table 151. Imipenem API Market Challenges
Table 152. Imipenem API Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Imipenem API
Figure 2. Global Imipenem API Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Imipenem API Market Share by Type in 2023 & 2030
Figure 4. Aseptic API Product Picture
Figure 5. Non-sterile API Product Picture
Figure 6. Global Imipenem API Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Imipenem API Market Share by Application in 2023 & 2030
Figure 8. Intramuscular Injection
Figure 9. Static Drops
Figure 10. Global Imipenem API Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Imipenem API Market Size (2019-2030) & (US$ Million)
Figure 12. Global Imipenem API Sales (2019-2030) & (KG)
Figure 13. Global Imipenem API Average Price (US$/G) & (2019-2030)
Figure 14. Imipenem API Report Years Considered
Figure 15. Imipenem API Sales Share by Manufacturers in 2023
Figure 16. Global Imipenem API Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Imipenem API Players: Market Share by Revenue in 2023
Figure 18. Imipenem API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Imipenem API Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Imipenem API Sales Market Share by Country (2019-2030)
Figure 21. North America Imipenem API Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Imipenem API Sales Market Share by Country (2019-2030)
Figure 25. Europe Imipenem API Revenue Market Share by Country (2019-2030)
Figure 26. Germany Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Imipenem API Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Imipenem API Revenue Market Share by Region (2019-2030)
Figure 33. China Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Imipenem API Sales Market Share by Country (2019-2030)
Figure 44. Latin America Imipenem API Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Imipenem API Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Imipenem API Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Imipenem API Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Imipenem API by Type (2019-2030)
Figure 54. Global Revenue Market Share of Imipenem API by Type (2019-2030)
Figure 55. Global Imipenem API Price (US$/G) by Type (2019-2030)
Figure 56. Global Sales Market Share of Imipenem API by Application (2019-2030)
Figure 57. Global Revenue Market Share of Imipenem API by Application (2019-2030)
Figure 58. Global Imipenem API Price (US$/G) by Application (2019-2030)
Figure 59. Imipenem API Value Chain
Figure 60. Imipenem API Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
